Global Vertebroplasty and Kyphoplasty Market, By Product (Vertebroplasty, Kyphoplasty), End-Use (Hospitals, Ambulatory Surgery Centres) – Industry Trends and Forecast to 2029.
Vertebroplasty and Kyphoplasty Market Analysis and Size
According to the International Osteoporosis Foundation, osteoporosis causes more than 8.9 million fractures worldwide. A vertebral compression fracture is a common sign of osteoporosis that affects approximately 7,50,000 people in the United States each year, the majority of whom are women. Osteoporotic vertebral compression fractures can cause severe deformity and immobility complications. Patients who have intractable pain that is resistant to conservative treatment may benefit from vertebral augmentation procedures.
Data Bridge Market Research analyses that the vertebroplasty and kyphoplasty market which was USD 804.95 million in 2021, is expected to reach USD 1171.27 million by 2029, at a CAGR of 4.80% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Vertebroplasty and Kyphoplasty Market Scope and Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Million, Volumes in Units, Pricing in USD
Product (Vertebroplasty and Kyphoplasty), End-Use (Hospitals, Ambulatory Surgery Centres)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
Medtronic (Ireland), Alphatec Spine, Inc (U.S.), Stryker (U.S.), Merit Medical Systems (U.S.), Globus Medical (U.S.), IZI Medical Products (U.S.), ZAVATION (U.S.), RONTIS (Switzerland), G21 S.r.l. (Italy), SOMATEX Medical Technologies GmbH (Germany), BPB MEDICA (Italy), Laurane Medical LLC (France), Teknimed (France), Benvenue Medical (U.S.), Spine Wave, Inc. (U.S.), MEDAID Inc. (Singapore), Cardinal Health (U.S.), Joimax GmbH (Germany)
Verteoplasty is a minimally invasive spinal procedure in which bone cement is injected through a small hole in the skin into a fractured vertebra. Vertebroplasty relieves pain caused by compression fractures and stabilises the spine, thereby preventing further spinal dysfunction and improving quality of life. Kyphoplasty, is a type of spinal augmentation for compression fractures. This procedure relieves the pain caused by a vertebral fracture, stabilises the bone, and restores the height of the vertebral body, which has been reduced due to a compression fracture. Bone cement, also known as polymethyl-methacrylate, is injected into the fractured bone via a hollow needle during vertebroplasty.
In kyphoplasty, a balloon is inserted and inflated to expand the compressed vertebrae to their normal height, and then the space is filled with bone cement. Kyphosis is a modern spine surgery procedure used to stabilise vertebral compression fractures caused by osteoporosis, cancer, and other conditions.
Global Vertebroplasty and Kyphoplasty Market Dynamics
- Launch of new products
Rising product launches, partnerships, and acquisitions by top market players are expected to boost segment growth. For instance, Medtronic plc launched its Kyphon Assist Directional Cannula in the United States in May 2020 to treat spinal compression fractures caused by osteoporosis, cancer, or benign lesions. As a result, these factors are expected to drive the growth of the kyphoplasty devices in the market.
- Surge in adoption of technologically advanced products
Medical device advancements have allowed for the reconstruction of various equipment, such as Crosstrees Medical, Inc.'s PVA Pod System, a novel bone cement delivery technology that does not require an implanted device in the spine. Medtronic's Khphon bone cement has been available with a new indication for sacral vertebral fracture since June 2018. The use of vertebroplasty and kyphoplasty equipment in the health care industry is increasing due to new applications of existing devices and the development of new devices. This equipment is used to perform various spine surgeries. This is driving the vertebroplasty and kyphoplasty market.
- Rising geriatric population will act as an opportunity
In recent years, the geriatric population has grown. According to the World Health Organization's October 2021 update, one in every six people worldwide is expected to be 60 or older by 2030. At this point, the proportion of the population aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion. The world's population of people aged 60 and up is expected to double by 2050. (2.1 billion). The number of people aged 80 and up is expected to triple between 2020 and 2050, reaching 426 million. The most common fractures in osteoporosis patients are vertebral compression fractures, the geriatric population is more prone to osteoporosis. As a result, the market is expected to grow.
- High cost of treatment
Spinal surgeries are extremely expensive and in some cases, are not covered by insurance. This increases the burden on the patient and family, making it unaffordable for low-income people. In the United States, for instance, the cost of lumbar fusion spine surgery exceeds $45,000, which does not include the costs of imaging, diagnostics, medications, hospital care, and rehabilitation services, among other things.
This vertebroplasty and kyphoplasty market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vertebroplasty and kyphoplasty market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Vertebroplasty and Kyphoplasty Market
COVID-19 has spread throughout the world and has met the epidemiologic criteria for a pandemic. In this terrifying situation, standard medical practise was severely impacted, emphasising the treatment of coronavirus patients. The spine section was completely reorganised to reduce the rate of contamination of medical staff and patients during hospitalisation. The North American Spine Society (NASS) issued a guidance document in April 2020 that included clinical considerations and recommendations for surgeries and procedures classified as emergent, urgent, or elective.
- In April 2022, Nanox announced FDA approval for HealthOST Device, an AI software monitoring vertebral compression fractures and low bone density, which are frequently associated with osteoporosis.
- In August 2020, IZI Medical Products launched a osteo-site vertebral balloon ("Osteo-Site Balloon") for vertebral augmentation. It rounds out IZI's treatment options for vertebral compression fracture (VCF), which also include osteo-site vertebroplasty, osteo-site balloon kyphoplasty, blazer curved needle augmentation, and Kiva PEEK Implant-based augmentation.
- In August 2021, IZI Medical Products, LLC announced the official launch of Vertefix HV Cement. Vertefix HV is a novel technology for vertebroplasty and kyphoplasty procedures that meets the demand for real-time flow visualisation during cement injection. Product introductions are expected to boost market growth.
Global Vertebroplasty and Kyphoplasty Market Scope
The vertebroplasty and kyphoplasty market is segmented on the basis of product, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Cement mixing
- Delivery device
- Needles and balloons
- Cement mixing
- Delivery device
- Ambulatory Surgery Centres
Vertebroplasty and Kyphoplasty Market Regional Analysis/Insights
The vertebroplasty and kyphoplasty market is analysed and market size insights and trends are provided by country, product, end-user and application as referenced above.
The countries covered in the vertebroplasty and kyphoplasty market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the vertebroplasty and kyphoplasty market owing to factors such as better healthcare infrastructure, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the United States.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to increasing older population and growing acceptance of the procedure are aiding the market growth. Similarly, factors such as availability of advanced methods in fracture stabilization, limitations of the conventional approach, increasing incidence of vertebral compression fracture, rising cases of osteoporosis.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The vertebroplasty and kyphoplasty market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for vertebroplasty and kyphoplasty market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the vertebroplasty and kyphoplasty market. The data is available for historic period 2010-2020.
Competitive Landscape and Vertebroplasty and Kyphoplasty Market Share Analysis
The vertebroplasty and kyphoplasty market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vertebroplasty and kyphoplasty market.
Some of the major players operating in the vertebroplasty and kyphoplasty market are:
- Medtronic (Ireland)
- Alphatec Spine, Inc (U.S.)
- Stryker (U.S.)
- Merit Medical Systems (U.S.)
- Globus Medical (U.S.)
- IZI Medical Products (U.S.)
- ZAVATION (U.S.)
- RONTIS (Switzerland)
- G21 S.r.l. (Italy)
- SOMATEX Medical Technologies GmbH (Germany)
- BPB MEDICA (Italy)
- Laurane Medical LLC (France)
- Teknimed (France)
- Benvenue Medical (U.S.)
- Spine Wave, Inc. (U.S.)
- MEDAID Inc. (Singapore)
- Cardinal Health (U.S.)
- Joimax GmbH (Germany)